Page last updated: 2024-08-23

7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide and sirolimus

7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide has been researched along with sirolimus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, G; Ding, J; Gong, W; Han, T; He, G; Huang, L; Huang, S; Liang, J; Ning, B; Sun, W; Wang, H; Wen, W; Wu, K; Wu, M; Xie, W1

Other Studies

1 other study(ies) available for 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide and sirolimus

ArticleYear
Cyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesis.
    The Journal of biological chemistry, 2009, Nov-27, Volume: 284, Issue:48

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Animals; Antibiotics, Antineoplastic; Blotting, Western; Cell Line; Cell Transformation, Neoplastic; Cyclin D1; Epithelial Cells; Gene Expression; Hepatocytes; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Models, Biological; Mutation; Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Signal Transduction; Sirolimus

2009